Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Obes Rev (2022) 23(6):e13435
DON'T MISS THIS: South African court blocks pharmacy accused of selling unapproved Ozempic-style weight-loss drugs However, the surge in demand for semaglutide and tirzepatide has encouraged some businesses to manufacture and distribute unregistered copies outside permitted conditions
Ozempic isnt FDA-approved for PMOS, but some providers prescribe it off-label for potential benefits
Quick Stats of the GLP-1 Nutritional Support Market Industry Value (2025): USD 4.1 billion Forecast Value (2035): USD 13 billion Global CAGR (2025 to 2035): 12.2% Leading Segment in 2025: Protein & Macronutrient Blends (~43% share) Key Growth Region: East Asia Key Players: Nestl Health Science, Abbott, Herbalife, Unjury Protein, ProCare Health, Expansion is being shaped by clinical treatment protocols and broader reimbursement for weight loss and metabolic support
